Facility Type Predicts Completeness of Oncologic Resection and Survival in Biliary Tract Cancers

医疗机构类型可预测胆道癌肿瘤切除的完整性和生存率

阅读:3

Abstract

PURPOSE: Complete Oncologic Resection (COR) for biliary tract cancers (BTC) includes negative margin status and adequate lymphadenectomy, defined as retrieval of ≥ 6 lymph nodes. Whether these standards and their association with survival vary across facility types and BTC subtypes remains unclear. METHODS: Using the National Cancer Database (2004–2022), we identified adults undergoing curative-intent resection for Stage I-III BTC, excluding T1a gallbladder cancer. Facility types were compared for COR using nested logistic regression, adjusting for demographic and tumor factors. Overall survival (OS) was assessed using multivariable Cox proportional hazards models, with Kaplan-Meier (KM) analyses used to describe unadjusted, stratified survival patterns. RESULTS: Among 13,250 adults, 51.6% were treated at academic centers. Negative margins were achieved in 79.5% of academic versus 79.0% elsewhere, while adequate lymphadenectomy occurred in 48.2% versus 38.2%, respectively (p < 0.001). Non-academic programs had lower odds of COR (OR 0.78–0.94), and gallbladder cancer had the lowest odds of each COR component relative to other BTC subtypes (negative margins: OR 0.80, 95% CI 0.69–0.93; adequate lymphadenectomy: OR 0.77, 95% CI 0.68–0.88). Cox estimates showed higher mortality with positive margins (HR 1.80, 95% CI 1.71–1.89), inadequate lymphadenectomy (HR 1.22, 95% CI 1.16–1.28), incomplete oncologic surgery (HR 1.36, 95% CI 1.30–1.43), and non-academic facilities (HR 1.17, 95% CI 1.12–1.23). CONCLUSION: Academic centers more frequently deliver COR and are associated with improved survival, but lymphadenectomy benchmarks remain unmet across facility types. System-level interventions, including multidisciplinary collaboration and referral networks, are necessary to expand access to high-quality care and improve outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12029-026-01421-1.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。